PLUS THERAPEUTICS, Inc. Series S Warrant
PSTVZ
PSTVZ was delisted on the 26th of May, 2020.
0 hedge funds and large institutions have $0 invested in PLUS THERAPEUTICS, Inc. Series S Warrant in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $4K → $0 (-$4K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
-$1K |
| 3 |
Jane Street
New York
|
-$1K |
PSTVZ Hedge Fund Activity: Q2 2020 in Review
0 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in PLUS THERAPEUTICS, Inc. Series S Warrant (PSTVZ) for Q2 2020, worth a combined $0 — down 100% from $4K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PSTVZ and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was CVI Holdings, exiting entirely with an estimated $2K sold.
- 0 institutional investors held PLUS THERAPEUTICS, Inc. Series S Warrant (PSTVZ) as of Q2 2020, down from 5 in Q1 2020.
- Funds reported $0 of PLUS THERAPEUTICS, Inc. Series S Warrant stock for Q2 2020, down 100% quarter-over-quarter.
- 0 funds opened new PLUS THERAPEUTICS, Inc. Series S Warrant positions in Q2 2020 and 5 closed out, a net change of -5 holders.
- The largest PLUS THERAPEUTICS, Inc. Series S Warrant seller in Q2 2020 was CVI Holdings, an estimated $2K sold.
Based on aggregated 13F filings for Q2 2020.